Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: Visual Display Users With Previously Undiagnosed Dry Eye
In brief
Two study arms - sham and treatment; There will be a cross over of the sham group to the treatment group at day 15.
Key facts
- Study ID
- NCT04763018
- Run by
- Olympic Ophthalmics, Inc.
- People needed
- 35
- Starts
- 2021-02-17
- Expected to finish
- 2021-06-01
- Last updated by the study team
- 2021-02-21
Who can join
Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- > 6hrs visual display terminal
- OSDI > 13
- One of: SChirmer < 10, One quadrant staining > 2, or Meibomian Gland expression <12
You may not qualify if…
- Opinion of investigator that subject not be in the study
Where it is running
- Fishman Vision — Palo Alto, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.